Literature DB >> 21480239

Experimental models to study lymphatic and blood vascular metastasis.

Lu Chen1, Byron Hann, Lily Wu.   

Abstract

As a model system for the understanding of human cancer, the mouse has proved immensely valuable. Indeed, studies of mouse models have helped to define the nature of cancer as a genetic disease and demonstrated the causal role of genetic events found in tumors. As an experimental platform, they have provided critical insight into the process of tumor metastasis in the lymphovascular system. Once viewed with skepticism, mouse models are now an integral arm of basic and clinical cancer research. The use of a genetically tractable organism that shares organ systems and an immense degree of genetic similarity to humans provides a means to examine multiple features of human disease. Mouse models enable development and testing of new approaches to disease prevention and treatment, identification of early diagnostic markers and novel therapeutic targets, and an understanding of the in vivo biology and genetics of tumor initiation, promotion, progression, and metastasis. This review summarizes recent mouse models for lymphangiogenesis and the process of lymphovascular metastasis, focusing on the use of the cornea as an experimental platform for lymphangiogenesis in inflammation and immunity, and on the use of molecular and viral vector mediated imaging and to identify and monitor lymph node metastases of prostate cancer.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21480239      PMCID: PMC3201795          DOI: 10.1002/jso.21794

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  95 in total

Review 1.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

2.  Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.

Authors:  Diane M Roberts; Anjali Nanda; Menzo J E Havenga; Peter Abbink; Diana M Lynch; Bonnie A Ewald; Jinyan Liu; Anna R Thorner; Patricia E Swanson; Darci A Gorgone; Michelle A Lifton; Angelique A C Lemckert; Lennart Holterman; Bing Chen; Athmanundh Dilraj; Angela Carville; Keith G Mansfield; Jaap Goudsmit; Dan H Barouch
Journal:  Nature       Date:  2006-04-16       Impact factor: 49.962

3.  Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.

Authors:  David M Schuster; John R Votaw; Peter T Nieh; Weiping Yu; Jonathon A Nye; Viraj Master; F DuBois Bowman; Muta M Issa; Mark M Goodman
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

4.  Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells.

Authors:  Lu Chen; Claus Cursiefen; Stefano Barabino; Qiang Zhang; M Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

5.  In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus.

Authors:  Hiroyuki Kishimoto; Toru Kojima; Yuichi Watanabe; Shunsuke Kagawa; Toshiya Fujiwara; Futoshi Uno; Fuminori Teraishi; Satoru Kyo; Hiroyuki Mizuguchi; Yuuri Hashimoto; Yasuo Urata; Noriaki Tanaka; Toshiyoshi Fujiwara
Journal:  Nat Med       Date:  2006-10-01       Impact factor: 53.440

6.  Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.

Authors:  Karin Jennbacken; Christina Vallbo; Wanzhong Wang; Jan-Erik Damber
Journal:  Prostate       Date:  2005-10-01       Impact factor: 4.104

7.  Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach.

Authors:  Mai Johnson; Makoto Sato; Jeremy Burton; Sanjiv S Gambhir; Michael Carey; Lily Wu
Journal:  Mol Imaging       Date:  2005 Oct-Dec       Impact factor: 4.488

8.  Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.

Authors:  Takako Yamaguchi; Jin Lee; Hiroji Uemura; Takeshi Sasaki; Nobukazu Takahashi; Takashi Oka; Kazuya Shizukuishi; Hisashi Endou; Yoshinobu Kubota; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-15       Impact factor: 9.236

9.  The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.

Authors:  Timothy A Masterson; Fernando J Bianco; Andrew J Vickers; Christopher J DiBlasio; Paul A Fearn; Farhang Rabbani; James A Eastham; Peter T Scardino
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

10.  Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.

Authors:  Meit Björndahl; Renhai Cao; L Johan Nissen; Steve Clasper; Louise A Johnson; Yuan Xue; Zhongjun Zhou; David Jackson; Anker Jon Hansen; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

View more
  13 in total

1.  Live imaging of newly formed lymphatic vessels in the cornea.

Authors:  Don Yuen; Xiufeng Wu; Alex C Kwan; Jeffrey Ledue; Hui Zhang; Tatiana Ecoiffier; Bronislaw Pytowski; Lu Chen
Journal:  Cell Res       Date:  2011-11-15       Impact factor: 25.617

2.  Watching lymphatic vessels grow by making them glow.

Authors:  Steven T Proulx; Michael Detmar
Journal:  Cell Res       Date:  2011-11-29       Impact factor: 25.617

3.  Corneal lymphatic valve formation in relation to lymphangiogenesis.

Authors:  Tan Truong; Eric Huang; Don Yuen; Lu Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-25       Impact factor: 4.799

4.  Increased lymphangiogenesis and hemangiogenesis in infant cornea.

Authors:  Don Yuen; Rose Leu; Anna Sadovnikova; Lu Chen
Journal:  Lymphat Res Biol       Date:  2011       Impact factor: 2.589

5.  Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.

Authors:  Hui Zhang; Sammy Grimaldo; Don Yuen; Lu Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-17       Impact factor: 4.799

6.  Protective effects of matrix metalloproteinase-12 following corneal injury.

Authors:  Matilda F Chan; Jing Li; Anthony Bertrand; Amy-Jo Casbon; Jeffrey H Lin; Inna Maltseva; Zena Werb
Journal:  J Cell Sci       Date:  2013-06-26       Impact factor: 5.285

7.  Prox1-GFP/Flt1-DsRed transgenic mice: an animal model for simultaneous live imaging of angiogenesis and lymphangiogenesis.

Authors:  Wei Zhong; Xinbo Gao; Shuangyong Wang; Kyuyeon Han; Masatsugu Ema; Susanne Adams; Ralf H Adams; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Angiogenesis       Date:  2017-08-09       Impact factor: 9.596

8.  Novel characterization of lymphatic valve formation during corneal inflammation.

Authors:  Tan Truong; Eda Altiok; Don Yuen; Tatiana Ecoiffier; Lu Chen
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

9.  Conjunctival lymphatic response to corneal inflammation in mice.

Authors:  Tatiana Ecoiffier; Anna Sadovnikova; Don Yuen; Lu Chen
Journal:  J Ophthalmol       Date:  2012-03-15       Impact factor: 1.909

10.  Walking the Line: A Fibronectin Fiber-Guided Assay to Probe Early Steps of (Lymph)angiogenesis.

Authors:  Maria Mitsi; Martin Michael Peter Schulz; Epameinondas Gousopoulos; Alexandra Michaela Ochsenbein; Michael Detmar; Viola Vogel
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.